期刊文献+

siRNA介导的STAT3基因沉默对宫颈癌HeLa细胞凋亡和化疗敏感性的影响 被引量:3

Effects of knockdown of STAT3 induced by small interference RNA on apoptosis of HeLa cells and chemoperapeutic sensitivity
原文传递
导出
摘要 目的:应用siRNA介导的STAT3基因沉默,研究其对HeLa细胞凋亡和化疗敏感性的影响。方法:体外合成靶向STAT3的siRNA-1和siRNA-2,并用脂质体转染HeLa细胞,RT-PCR检测干扰STAT3 mRNA敲减的效率,蛋白质印迹法检测敲减后STAT3蛋白的表达;通过记录生长曲线观察干扰后细胞的增殖情况。用Annexin V/PI双染,结合流式细胞仪检测细胞早期凋亡率。MTT法检测肿瘤细胞对几种化疗药物的敏感性。结果:siRNA使STAT3表达下调,mRNA水平抑制率为74.8%和60.4%;蛋白表达水平抑制达68.0%和59.0%。干扰后HeLa细胞增殖缓慢,早期凋亡率明显增加。对顺铂、长春瑞滨和吉西他滨有增敏作用。结论:siRNA介导的STAT3沉默可以抑制宫颈癌HeLa细胞的增殖,诱导凋亡,增加对化疗药物的敏感性,可望成为一种新的治疗策略。 OBJECTIVE:To investigate the apoptosis of HeLa cells induced by RNA interference (RNAi) targeting STAT3 and the effect on chemotherapeutic sensitivity. METHODS: Small interference RNA (siRNA-1 and -2) targeting STAT3 was generated by chemical synthesis and transfected into HeLa cells. The variance of STAT3 expressions was detected by semi-quantitive RT-PCR and Western blot. The proliferation and apoptosis of the transected cells were respectively detected by typan blue exclusion and FCM essay(Annexin V/PI). MTT method was used to detect the chemoperapentic sensitvity. RESULTS: Both mRNA and protein levels of STAT3 in the HeLa cells were remarkably decreased after transfection with the two siRNAs,inhibited the reproduction and increased the apoptosis and the sensitivity to the chemotherapeutic drug. The mRNA inhibition rates were 74.8% and 60.4%. The protein inhibition rates were 68.0% and 59.0%. CONCLUSION: In vitro,STAT3 siRNA-1 and siRNA-2 transfection can specifically silence the gene expression and may induce apoptosis of HeLa cells,furthermore,elevate the sensitivity to chemotherapeutic drug.
出处 《中华肿瘤防治杂志》 CAS 2009年第18期1387-1390,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 陕西省科技攻关项目(No.2007k09-08)
关键词 RNA 小分子干扰 基因表达 细胞凋亡 宫颈肿瘤/病理学 转染 RNA small interfering gene expression apoptosis cervix neoplasms/pathology transfenction
  • 相关文献

参考文献15

  • 1Jove R. Preface: STAT signaling[J]. Oncogene, 2000, 19(21): 2466-2467.
  • 2Bromberg J F, Wrzeszczynska M H, Devgan G, et al. Stat3 as anoncogene[J]. Cell, 1999, 98(3):295-303.
  • 3张文,王雅杰,薛春燕,傅强.乳腺癌组织磷酸化STAT3表达及其与淋巴结转移关系的研究[J].中华肿瘤防治杂志,2008,15(6):440-443. 被引量:9
  • 4朱青,张王刚,王立锋,王芳,张勇,杨安钢.Hsp701A基因的RNA干涉对HepG2细胞化疗敏感性的影响[J].细胞与分子免疫学杂志,2006,22(5):606-608. 被引量:3
  • 5Yu H, Jove R. The STATs of cancer--new molecular targets come of age[J]. Nat Rev Cancer, 2004, 4(2): 97- 105.
  • 6Niu G, Wright K L, Ma Y, et al. , Role of Star3 in regulating p53 expression and function[J]. Mol Cell Biol, 2005, 25(17): 7432-7440.
  • 7Gritsko T, Williams A, Turkson J, et al. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells [J].Clin Cancer Res, 2006, 12(1): 11-19.
  • 8韩安家,宗永生,何洁华,林素暇,梁英杰.STAT3在鼻咽癌中的表达特征及其与bcl-2和LMP1表达的关系[J].肿瘤防治杂志,2005,12(2):81-84. 被引量:12
  • 9Page C, Huang M, Jin X, et al. , Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells[J].Int J Oncol, 2000,17(1):23 -28.
  • 10Chen C L, Hsieh F C, Lieblein J C, et al. Star3 activation in hu man endometrial and cervical cancers[J]. Br J Cancer, 2007, 96(4) : 591-599.

二级参考文献32

  • 1王禹,张颖超,韩喜春,关文曾.乳腺癌组织中癌基因STAT3的表达及临床意义[J].中国老年学杂志,2005,25(9):1036-1037. 被引量:6
  • 2Shuai K, Stark G R, Kerr I M, et al. A single phosphotyrosine residue of STAT 91 required for gene activation by interferon gamma[J]. Science, 1993, 261(5129): 1744-1746.
  • 3Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis[J]. Oncogene, 2000, 19(21): 2474-2488.
  • 4Song J I, Rubin-Grandis J. STAT signaling in head and neck cancer[J]. Oncogene,2000, 19(21): 2489-2495.
  • 5Weber-Nordt R M, Egen C, Wehinger J, et al. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell line[J]. Blood, 1996, 88(3): 809 816.
  • 6Zushi S, Shinomura Y, Kiyohara T. et al. STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells[J]. Int J Cancer, 1998, 78(3): 326-330.
  • 7Hironaka T, Nagasaki M, Morikawa S, et al. Detecfion of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line ( HLN STL-C) by in situ hybridization oligonucleotide probes[J]. J Virol Methods, 1993,44(2-3) : 141-154.
  • 8Gires O, Kohlhuber F, Kilger E, et al. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins[J]. EMBOJ, 1999. 18(11): 3064-3073.
  • 9Chen H L, Lee J M, Wang Y L, et al. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity[J]. Proc Natl Acad USA, 1999, 96(16): 9339-9344.
  • 10Chen H L, Lee J M, Zong Y S, et al, Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors[J],J Virol, 2001,75(6): 2929-2937.

共引文献21

同被引文献57

  • 1郝敏,王静芳.宫颈癌流行病学研究与调查[J].国外医学(妇幼保健分册),2005,16(6):404-406. 被引量:91
  • 2李立,刘启才,刘立志,欧陕兴,吕衍春,刘学文,崔春艳,吴沛宏.人转化铁受体基因的克隆和表达[J].中华放射学杂志,2007,41(5):535-538. 被引量:1
  • 3Parkin D M, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer, 2001, 94 (2) : 153-156.
  • 4Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ, 2001, 164 ( 7 ) : 1017-1025.
  • 5D'Andrilli G, Bovicelli A, Giordano A. HPV vaccines: state of the art. J Cell Physiol,2010,224 ( 3 ) :601-604.
  • 6Weissleder R. Molecular imaging: exploring the nextfrontier. Radiology, 1999,212 ( 3 ) : 609-614.
  • 7Hogemann-Savellano D, Bos E, Blondet C, et al. The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia, 2003 ,5(6) :495-506.
  • 8Hoffman JM, Gambhir SS. Molecular imaging: the vision and opportunity for radiology in the future. Radiology,2007, 244( 1 ) :39-47.
  • 9Vande Velde G, Baekelandt V, Dresselaers T, et al. Magnetic resonance imaging and spectroscopy methods for molecular imaging. Q J Nucl Med Mol Imaging, 2009,53 (6) :565-85.
  • 10Westmeyer GG, Jasanoff A. Genetically controlled MRI contrast mecha- nisms and their prospects in systems neuroscience research. Magn Reson Imaging, 2007, 25 (6) : 1004-1010.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部